The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci

AI is increasingly being applied to drug discovery, with Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics, and Absci building computational discovery platforms and advancing drug pipelines. The article frames these developments as a broader shift in how therapeutics are identified and developed, but provides no quantified results or guidance changes. Overall, it reads as informative rather than immediately market-moving.

Analysis

AI is increasingly being applied to drug discovery, with Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics, and Absci building computational discovery platforms and advancing drug pipelines. The article frames these developments as a broader shift in how therapeutics are identified and developed, but provides no quantified results or guidance changes. Overall, it reads as informative rather than immediately market-moving.